STOCK TITAN

Celestica (CLS) director receives 237 director share units in Form 4 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Celestica Inc. reported a routine insider equity award for one of its directors. On 12/31/2025, the director received 237 director share units, which are a type of derivative security tied to Celestica common shares. These units were granted at a price of $0 and increase the director’s holdings to 992 derivative securities after the transaction.

Each director share unit represents a contingent right to receive one Celestica common share, or an equivalent cash amount, at the company’s discretion when the holder stops serving as a director, consultant, or other service provider. The filing indicates the director’s ownership is held directly and reflects standard equity-based compensation rather than an open‑market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Maletira Amar
Role Director
Type Security Shares Price Value
Grant/Award Director Share Units 237 $0.00 --
Holdings After Transaction: Director Share Units — 992 shares (Direct)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Maletira Amar

(Last) (First) (Middle)
5140 YONGE STREET
SUITE 1900

(Street)
TORONTO A6 M2N 6L7

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Director Share Units (1) 12/31/2025 A 237 (1) (1) Common Shares 237 $0 992 D
Explanation of Responses:
1. Each director share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to serve the Issuer as any of a director, consultant or other service provider.
/s/ Tracy Connelly McGilley, attorney-in-fact 01/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Celestica Inc (CLS) disclose in this Form 4?

Celestica disclosed that a director received 237 director share units on 12/31/2025, increasing the director’s holdings of derivative securities to 992 units held directly.

What are Celestica (CLS) director share units and how are they settled?

Each director share unit gives the holder a contingent right to receive one Celestica common share or an equivalent cash amount, at the company’s discretion, when the holder ceases serving as a director, consultant, or other service provider.

Was the Celestica (CLS) director equity transaction a purchase or a grant?

The Form 4 shows a grant of director share units with a price of $0, indicating it is equity compensation rather than an open‑market purchase or sale.

How many Celestica (CLS) derivative securities does the director own after this transaction?

Following the grant of 237 director share units, the Form 4 reports that the director beneficially owns 992 derivative securities, held directly.

When will the Celestica (CLS) director share units be delivered to the holder?

The director share units become payable when the holder ceases to serve Celestica as a director, consultant, or other service provider, at which time they may be settled in shares or cash at the issuer’s discretion.

Does this Celestica (CLS) Form 4 indicate use of a Rule 10b5-1 trading plan?

The form includes a checkbox for indicating transactions under a Rule 10b5-1(c) plan, but the excerpt does not show this box marked for the reported director share unit grant.